Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Azadirachta indica (commonly known as neem) is a tree native to the Indian subcontinent and widely grown in tropical and subtropical regions. Extracts from its leaves, seeds, bark, and other parts are used in traditional medicine for a variety of purposes including treatment of malaria, diabetes, worms (anthelmintic), cardiovascular diseases, skin diseases, dental health (oral dentifrice), lice treatment and as an insecticide or insect repellent[1][2][3][4]. Neem contains numerous bioactive compounds such as azadirachtin (noted for its insecticidal properties), nimbin, nimbidin, nimbolide (with anti-inflammatory and antimicrobial effects), quercetin (antibacterial/antifungal activity), beta-sitosterol and various limonoids[3][5]. The mechanism of action is complex due to the presence of multiple active phytochemicals; reported activities include antioxidant effects and modulation of genetic pathways involved in inflammation and infection[3]. Clinical evidence supporting specific therapeutic uses is limited. Neem products are manufactured primarily by extraction from plant material; they are not developed by pharmaceutical companies but rather produced by natural product manufacturers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on azadirachta indica.